Article · Volume 8, Issue 3 · pp. 220–224
Exploring Troublesome Symptom and Problems Experienced by Cancer Patients Undergoing Chemotherapy
Harminder Singh1, Raja Paramjeet Singh2, Baltej Singh3, Kanwardeep Kaur Tiwana3
- 1Associate Professor Pharmacology, G.G.S. Medical College, Faridkot-151203, (Baba Farid University of Health Sciences), Punjab, INDIA.
- 2Department of Onco-Radiation, Baba Farid University of Health Sciences, Pharmacology, Faridkot, Punjab, INDIA.
- 3Department of Biostatistic, Baba Farid University of Health Sciences, Community Medicine, Faridkot, Punjab, INDIA.
- 4Department of Pathology, Baba Farid University of Health Sciences, Pathology Faridkot, Punjab, INDIA.
Abstract
Objective: The objective of this cross-sectional, non interventional 8-months observational study was to investigate the prevalence, type and risk factors of Drug related problem (DRPs) in cancer patients admitted to the Oncology Department of Guru Gobind Singh Medical College, Faridkot, Punjab.Methods:A cross-sectional 8 months study was conducted from January to August 2015 at the Oncology Department of Guru Gobind Singh Medical College, Faridkot, Punjab. A total of 283 cancer patients were recruited in the present investigation analysis.Results: A total of 283 cancer patients participated in this current study, out of which 135 (47.70%) were males and 148 (52.30%) were females. Adverse drug reactions (ADRs) were the most common DRP, nausea and vomiting was the most common ADR (155). Female subjects experienced more DRPs 56% as compare to 44% in male cancer survivors.Conclusion: This study showed that DRPs were common in our setup and the risk factors associated with DRPs were female gender, number of medications, Body mass index and extremes age (in year) ranges. Early detection and timely intervention is the key to ensure a better therapeutic outcome.
Keywords: Cancer Chemotherapy; Drug Related Problems; Adverse drug reactions; Drug-drug interactions; Cytotoxic agents; Oncology
The full text of this article is available as a PDF. Open the PDF.
